Outcome of therapy in biopsy proven lupus nephritis with cyclophosphamide or mycophenolate: Registry data from a South Indian tertiary care center
Background: Cyclophosphamide and mycophenolate are the currently proposed first-line agents for induction in lupus nephritis (LN). In this study, we analysed the response rates with the three different induction regimens currently available for LN. Methods: Patients with biopsy-proven LN with data a...
Main Authors: | Keerthi Talari, Rajendra Varaprasad Irlapati, Megha Uppin, Liza Rajasekhar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=2;spage=76;epage=80;aulast=Talari |
Similar Items
-
Mycophenolate versus cyclophosphamide for lupus nephritis
by: M Sahay, et al.
Published: (2018-01-01) -
Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
by: Arun Sedhain, et al.
Published: (2018-07-01) -
Retrospective comparison of cyclophosphamide and mycophenolate mofetil in lupus nephritis at Groote Schuur Hospital nephrology unit
by: Sogayise, Phelisa
Published: (2021) -
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis
by: Jennifer C Cooper, et al.
Published: (2018-10-01) -
The Effectiveness and Safety of Mycophenolate Mofetil in Lupus Nephritis
by: Elyan, Mazen
Published: (2008)